CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, speaks with PharmaVOICE at DIA 2017 on how small to mid-sized life sciences organizations select EDC vendors, the concept of “Unified” in an eClinical suite, the pain points for end-users, and the evolution of Axiom’s Fusion eClinical Suite.
Choosing the Right EDC/DM Partner: Critical Considerations for Small to Medium Sized Life Sciences Organizations
CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, is featured in PharmaVOICE’s June 2017 edition for feature article “Choosing the Right EDC/DM Partner: Critical Considerations for Small to Medium Sized Life Sciences Organizations”. ARTICLE EXCERPT: Whether you are a start-up pharmaceutical or biotech company, a medical devices innovator, or an established organization you want to be equipped with the …